Keyphrases
Receptor Profile
100%
Leukocyte Subsets
100%
Neovascular Age-related Macular Degeneration (nAMD)
100%
Treatment Failure
100%
Chemokine Receptor
100%
Retinal Thickness
80%
Chemokine Expression
60%
Expression Pattern
60%
CD8+ T Cells
40%
Non-responders
40%
Monocytes
40%
Treatment Response
40%
Subretinal Fluid
40%
CCR1
40%
CCR3
40%
Group-specific
20%
Prospective Observational Study
20%
Good Responders
20%
C-C Chemokine Receptor Type 5 (CCR5)
20%
Immune Dysfunction
20%
Potential Correlation
20%
CCR2
20%
Receptor Expression
20%
Optical Coherence Tomography
20%
Personalized Treatment
20%
Intravitreal Anti-vascular Endothelial Growth Factor Injection
20%
Partial Responder
20%
Loading Dose
20%
Age-related Macular Degeneration
20%
Treatment-naïve Patients
20%
Complete Regression
20%
Chemokines
20%
CXCR3
20%
CX3CR1
20%
Intergroup Difference
20%
Anti-vascular Endothelial Growth Factor Therapy
20%
Flow Cytometry
20%
Correlation Network
20%
CD4+ T Cells
20%
Expression Level
20%
Medicine and Dentistry
Chemokine Receptor
100%
Leukocyte
100%
Wet Macular Degeneration
100%
Chemokine
80%
Treatment Response
40%
Cytotoxic T-Cell
40%
Chemokine Receptor CX3CR1
20%
Receptor Expression
20%
Age Related Macular Degeneration
20%
Flow Cytometry
20%
Immune Disorder
20%
Endothelial Cell Growth Factor
20%
Subretinal Fluid
20%
Optical Coherence Tomography
20%
T-Helper Cell
20%
Cohort Study
20%
Immunology and Microbiology
Leukocyte
100%
Chemokine Receptor
100%
Chemokine
80%
Liquid
40%
Cytotoxic T-Cell
40%
Endothelial Cell Growth Factor
20%
CCR1
20%
CX3CR1
20%
Immune System Disorders
20%
Optics
20%
T-Helper Cell
20%
CXCR3
20%
CCR2
20%
Chemokine Receptor CCR1
20%
CCR5
20%
Pharmacology, Toxicology and Pharmaceutical Science
Chemokine Receptor CX3CR1
20%